Friday, May 8, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Contrarian

Failure to Include Black Communities in Health Policy Public Engagement Perpetuates Health Disparities

The Conversation by The Conversation
April 3, 2024
in Contrarian
0
Failure to Include Black Communities in Health Policy Public Engagement Perpetuates Health Disparities

Failure to include Black communities in health policy public engagement perpetuates health disparities

meeting room
Not engaging Black communities meaningfully in health and other policy-making processes has been a critical failure, reflecting a history of systemic racism, marginalization and political indifference.
(Nappy.co), CC BY

Alpha Abebe, McMaster University and Rhonda C. George, McMaster University

It is time for us to accept that policy failure and lack of community engagement in policy decision-making go hand-in-hand. The fact that the communities with the worst health outcomes are also the communities least likely to be meaningfully engaged in health policy decision-making should not be a surprise.

As it stands, a growing body of evidence suggests that while many decision-making bodies proclaim publicly that they want input from racialized and other marginalized communities, many institutions are not willing to listen to, accept or integrate what those communities have to say.

Broad systemic problems caused by longstanding exclusion and privilege are increasingly being acknowledged as overdue for correction. However, these complex issues are far too often papered over with helpful-sounding but empty rhetoric and symbolic and performative gestures of inclusion.

Over time, more and more people are coming to acknowledge that proclaiming to be inclusive while not actually doing substantive work is simply another tactic for preserving the status quo.

Health-care disparities

Our research, as part of the Public Engagement in Health Policy team, examines two key things:

  1. How, and to what extent, Black communities have been traditionally engaged in health policymaking; and,
  2. How, through creating their own health-focused solutions and interventions, Black communities’ self-advocacy and mobilization can provide great insight into persistent health system and policy gaps, and what potential solutions can look like.

In health-care systems, measurable outcomes such as disease prevalence and outcomes and indicators of trust in medical systems show that the system has chronically failed Black communities and is long overdue for systemic change.

The pandemic made these cracks painfully clear and very difficult to ignore.

Black communities in Canada and the United States are at higher risk for contracting COVID-19, have been dying at disproportionate and alarming rates, and suffer greater negative economic impacts.

A health-care worker in PPE about to swab a patient's throat
Black communities in Canada and the United States are at higher risk for contracting COVID-19 and have been dying at disproportionate and alarming rates.
THE CANADIAN PRESS/Paul Chiasson

We have known for some time that social determinants such as race, social class, education and environment influence health outcomes in both everyday and emergency situations.

Resolving the all-too-abundant disparities demands making room to hear from the people who aren’t getting the health care they need, but that isn’t happening enough, and when it does, it clearly isn’t having the necessary effect.

A recent review of government-initiated public and patient engagement activities in health policy from 2001-21 showed that only 14 per cent of 132 cases even mentioned prioritizing or engaging with marginalized populations.

All this raises the question, who really is “the public” in public engagement — and how legitimate and effective can such processes be when there are such critical gaps in representation and voice?

In response to this question, some scholars have argued that activities engaging the public in creating health policy are often merely performative “spectacles of public participation.”

They are prone to political interference, are often inadequately resourced and can result in unfulfilled expectations. They can also be self-selecting and deliberately designed to make inclusive engagement difficult.

Critical scholars have also pointed to processes that favour amenable, acquiescent perspectives that do not disrupt the status quo, while devaluing, co-opting and delegitimizing dissenting and critical voices.

Critical questions

If we are prepared to reckon with why this is happening, there are some critical questions we should be asking as researchers, health-care providers, activists and policy-makers.

What do we think we know about the needs and desires of Black communities in Canada as it relates to their health, and where does this knowledge come from? How have we historically engaged Black communities in health policy-making in Canada? To what extent are Black communities actually represented in the public engagement processes we speak about? Are we even evaluating which communities our public engagement processes actually engage?

Three people sitting at a table with laptops; two are watching the third as she speaks
Some scholars have argued that activities engaging the public in creating health policy are often merely performative ‘spectacles of public participation.’
(Nappy.co), CC BY

What challenges have we encountered when attempting to engage Black communities in these processes, and to what do we attribute these challenges?

Why are we not more alarmed by the disparities in outcomes for Black and other marginalized communities during COVID-19 and more broadly?

These are not technical issues but existential questions about the efficacy of our health systems and policies, and who these systems are traditionally designed to serve.

Finally, while there is vital “grey” or non-academic data captured by practitioners and community organizations (such as white papers, research reports, governmental publications, and policy, organizational and institutional analyses), it is essential that the health needs and experiences of Black communities in Canada be studied rigorously and ethically and reflected in academic literature.

It is therefore critical that we continue to advocate for the collection of race-based health data across Canada to strengthen health-equity discussions and policy reform.

Veneer of action

One of the profound impacts of the Black Lives Matter movement, particularly following the murders of George Floyd and Breonna Taylor, has been growing exasperation with the ways politicians and institutions often feign ignorance about the systemic barriers and forms of violence Black communities have long faced in their daily lives.

Symbolic acts of anti-racism that present a veneer of action rather than substantive structural change only add insult to injury. For example, when engaging marginalized communities, recruiting methods often favoured privileged populations, and one-off methods such as surveys were common, rather than substantively engaging marginalized communities in problem-solving.

A man with his hands in the air speaking to others
It is essential that the health needs and experiences of Black communities in Canada be studied rigorously and ethically and reflected in academic literature.
(Shutterstock)

While we continue to pursue more research, we need simultaneous and courageous conversations at policy tables that begin with a radical new level of honesty.

This means acknowledging that not engaging Black communities meaningfully in health and other policy-making processes has been a critical failure, reflecting a history of systemic racism, marginalization, and political indifference. It needs to be tackled with focus, humility, intentionality, and imagination.

In other words, what got us here won’t get us there.

We also need to understand that Black communities are not sitting by idly in a burning house waiting to be engaged. They are often out there, self-mobilizing, developing systems of mutual aid, building sophisticated community infrastructure and making their voices and demands heard. This work should be visible, lauded and properly resourced — not sidelined.

All forms of consultation and decision-making require openness to diverse views, which means shifting away from the top-down approaches governments have traditionally employed in forming health policy.

To be truly transformative, public engagement in health policy must reflect the agency, diversity, and interconnectivity of all communities.

With that said, if we begin any of this work without Black and other underserved communities leading these discussions, we have missed the point entirely.

Alpha Abebe, Assistant Professor, Faculty of Humanities, McMaster University and Rhonda C. George, Researcher, Faculty of Humanities, McMaster University

This article is republished from The Conversation under a Creative Commons license. Read the original article.

ShareTweet
The Conversation

The Conversation

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

summary

An in-depth exploration of drug pricing, including key databases like NADAC, WAC, and ASP, and how they influence the pharmaceutical supply chain, policy, and patient advocacy. The episode also introduces MedPricer's innovative pricing intelligence platform, offering valuable insights for healthcare professionals, policymakers, and patients.

Chapters

00:00 Understanding Drug Pricing Dynamics
03:52 Exploring the Drug Pricing Database
10:07 Patient Advocacy and Drug Pricing
13:56 Market Intelligence in Drug Pricing
How NADAC, WAC, and ASP Shape Drug CostsDaily Remedy
YouTube Video X-Tfwy7XKEg
Subscribe

Policy Shift in Peptide Regulation

Clinical Reads

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

by Daily Remedy
April 19, 2026
0

Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • Geographic Price Dispersion as a Macro Signal: What Hospital Rate Variance Tells Investors About Regional Economic Health

    The Gross-to-Net Bubble

    0 shares
    Share 0 Tweet 0
  • Why Procurement Teams Now Study Failure Before Features

    0 shares
    Share 0 Tweet 0
  • Nonlinear Healthcare Models

    0 shares
    Share 0 Tweet 0
  • A Two Headed Monster – State Attorneys General and the Drug Enforcement Agency

    3 shares
    Share 0 Tweet 0
  • The Unit Problem Nobody Wants to Fix

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy